News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,675 Results
Type
Article (41364)
Company Profile (271)
Press Release (683030)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (205558)
Career Advice (2129)
Deals (35778)
Drug Delivery (116)
Drug Development (81486)
Employer Resources (179)
FDA (16520)
Job Trends (15050)
News (347983)
Policy (32962)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2578)
Accelerated approval (32)
Adcomms (25)
Allergies (139)
Alliances (49807)
ALS (167)
Alzheimer's disease (1662)
Antibody-drug conjugate (ADC) (307)
Approvals (16785)
Artificial intelligence (503)
Autoimmune disease (143)
Automation (37)
Bankruptcy (363)
Best Places to Work (11721)
BIOSECURE Act (20)
Biosimilars (193)
Biotechnology (176)
Bladder cancer (158)
Brain cancer (56)
Breast cancer (633)
Cancer (4767)
Cardiovascular disease (403)
Career advice (1788)
Career pathing (36)
CAR-T (275)
CDC (45)
Celiac Disease (2)
Cell therapy (731)
Cervical cancer (36)
Clinical research (69571)
Collaboration (1683)
Company closure (4)
Compensation (1138)
Complete response letters (55)
COVID-19 (2713)
CRISPR (87)
C-suite (813)
Cystic fibrosis (143)
Data (6149)
Decentralized trials (2)
Denatured (25)
Depression (134)
Diabetes (504)
Diagnostics (6693)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (242)
Drug pricing (193)
Drug shortages (31)
Duchenne muscular dystrophy (225)
Earnings (90318)
Editorial (55)
Employer branding (24)
Employer resources (156)
Events (117604)
Executive appointments (961)
FDA (19605)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1446)
Gene editing (192)
Generative AI (42)
Gene therapy (583)
GLP-1 (990)
Government (4683)
Grass and pollen (7)
Guidances (383)
Healthcare (18990)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (246)
Immuno-oncology (53)
Indications (103)
Infectious disease (2973)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (336)
IPO (16703)
IRA (49)
Job creations (3669)
Job search strategy (1499)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (550)
Leadership (31)
Legal (8024)
Liver cancer (91)
Longevity (14)
Lung cancer (641)
Lymphoma (372)
Machine learning (42)
Management (59)
Manufacturing (781)
MASH (162)
Medical device (13845)
Medtech (13898)
Mergers & acquisitions (20134)
Metabolic disorders (1278)
Multiple sclerosis (156)
NASH (17)
Neurodegenerative disease (310)
Neuropsychiatric disorders (87)
Neuroscience (2875)
Neurotech (1)
NextGen: Class of 2026 (6596)
Non-profit (4526)
Now hiring (65)
Obesity (605)
Opinion (263)
Ovarian cancer (164)
Pain (195)
Pancreatic cancer (223)
Parkinson's disease (280)
Partnered (34)
Patents (489)
Patient recruitment (471)
Peanut (55)
People (59048)
Pharmaceutical (62)
Pharmacy benefit managers (30)
Phase 1 (21680)
Phase 2 (30599)
Phase 3 (22839)
Pipeline (5083)
Policy (282)
Postmarket research (2578)
Preclinical (9193)
Press Release (64)
Prostate cancer (235)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (824)
Real estate (6000)
Recruiting (73)
Regulatory (24583)
Reports (53)
Research institute (2391)
Resumes & cover letters (370)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (147)
Series A (238)
Series B (184)
Service/supplier (12)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (41)
Startups (3640)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (87)
The Weekly (55)
Vaccines (988)
Venture capital (86)
Weight loss (392)
Women's health (87)
Worklife (19)
Date
Today (8)
Last 7 days (593)
Last 30 days (2194)
Last 365 days (29892)
2026 (2820)
2025 (30288)
2024 (35327)
2023 (40198)
2022 (51291)
2021 (55841)
2020 (54303)
2019 (46948)
2018 (35299)
2017 (32272)
2016 (31651)
2015 (37751)
2014 (31467)
2013 (26513)
2012 (28758)
2011 (29413)
2010 (27466)
Location
Africa (748)
Alabama (83)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39507)
Australia (6443)
California (11161)
Canada (3255)
China (1085)
Colorado (471)
Connecticut (470)
Delaware (332)
Europe (85109)
Florida (1662)
Georgia (353)
Hawaii (3)
Idaho (62)
Illinois (858)
India (63)
Indiana (515)
Iowa (22)
Japan (417)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1370)
Massachusetts (8000)
Michigan (320)
Minnesota (630)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (2979)
New Mexico (28)
New York (2945)
North Carolina (1440)
North Dakota (8)
Northern California (5438)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2253)
Puerto Rico (22)
Rhode Island (47)
South America (1137)
South Carolina (66)
South Dakota (1)
Southern California (4343)
Tennessee (172)
Texas (1724)
United States (39615)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (914)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
724,675 Results for "prestige brands inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
October 20, 2025
·
4 min read
Press Releases
Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™
January 9, 2026
·
4 min read
Press Releases
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
October 28, 2025
·
7 min read
Press Releases
Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025
September 25, 2025
·
1 min read
Press Releases
Aires Enters Collaboration Agreement with Leading Wellness Expert Gary Brecka’s Brand, The Ultimate Human
February 2, 2026
·
6 min read
Press Releases
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
December 4, 2025
·
5 min read
Press Releases
Avant Brands Announces Results for Q3 2025
October 16, 2025
·
11 min read
Press Releases
Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant
December 22, 2025
·
9 min read
Press Releases
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
October 9, 2025
·
24 min read
Drug pricing
New Details From Trump’s Drug Pricing Effort Put Branded Drugs in the Crosshairs
Drugmakers will be expected to commit to aligning U.S. prices with the lowest price set in a group of peer nations for all brand products across all markets that do not currently have generic or biosimilar competition.
May 20, 2025
·
1 min read
·
Annalee Armstrong
1 of 72,468
Next
